Synopsis
Synopsis
0
EU WC
0
KDMF
0
VMF
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
Annual Reports
NA
Regulatory FDF Prices
NA
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers


1. Feostat
2. Ferrocap
3. Fersaday
4. Fersamal
5. Ferval
6. Fumar
7. Galfer
8. Ircon
9. Nephro-fer
10. Palafer
11. Rulofer N
1. Iron(ii) Fumarate
2. 141-01-5
3. Feostat
4. Palafer
5. Galfer
6. Ircon
7. Ercoferro
8. Ferrofume
9. Tolferain
10. Cpiron
11. Hemoton
12. Toleron
13. Tolifer
14. Erco-fer
15. Ferrousfumarate
16. Iron(2+) Fumarate
17. Iron Fumarate
18. 2-butenedioic Acid (2e)-, Iron(2+) Salt (1:1)
19. Fumaric Acid, Iron(2+) Salt (1:1)
20. 2-butenedioic Acid (e)-, Iron(2+) Salt (1:1)
21. R5l488ry0q
22. 2-butenedioic Acid, (e)-, Iron(2+) Salt
23. Fersamal
24. Fumar
25. (e)-but-2-enedioate;iron(2+)
26. Feroton
27. Ferronat
28. Ferrone
29. Ferrotemp
30. Fumafer
31. Fumiron
32. Firon
33. One-iron
34. Fumar-f
35. Ferrocite
36. Fumaric Acid, Iron(2+) Salt
37. Ccris 6896
38. Einecs 205-447-7
39. Unii-r5l488ry0q
40. Ferrofumarate
41. Heferol
42. Orgasal
43. Ferrous Fumarate [usp:jan]
44. Feostat (tn)
45. Ferrum (tn)
46. Iron (as Fumarate)
47. Meterfer
48. Iron (as Ferrous Fumarate)
49. Schembl24284
50. Schembl24286
51. Ferrous Fumarate (jan/usp)
52. Ferrous Fumarate [ii]
53. Ferrous Fumarate [mi]
54. Ferrous Fumarate [fcc]
55. Ferrous Fumarate [jan]
56. Ferrous Fumarate [inci]
57. Dtxsid7047148
58. Ferrous Fumarate [vandf]
59. Chebi:31607
60. Amy8976
61. Ferrous Fumarate [mart.]
62. Ferrous Fumarate [who-dd]
63. Ferrous Fumarate [who-ip]
64. Hy-b1651
65. Einecs 231-731-5
66. Mfcd00058315
67. Akos015918237
68. Ferrous Fumarate [orange Book]
69. Db14491
70. Ferrosi Fumaras [who-ip Latin]
71. Ferrous Fumarate [ep Monograph]
72. Ferrous Fumarate [usp Monograph]
73. Iron (as Ferrous Fumarate) [vandf]
74. 2-butenedioic Acid (2e)-, Iron(2+) Salt
75. Cs-0013603
76. Norquest Fe Component Ferrous Fumarate
77. D01194
78. Ferrous Fumarate Component Of Norquest Fe
79. Lo Minastrin Fe Component Ferrous Fumarate
80. Minastrin 24 Fe Component Ferrous Fumarate
81. Q416370
82. 2-butenedioic Acid (2e)-, Iron(2+) Salt (1:?)
83. J-007445
84. J-521364
85. 7705-12-6
| Molecular Weight | 169.90 g/mol |
|---|---|
| Molecular Formula | C4H2FeO4 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 0 |
| Exact Mass | 169.930244 g/mol |
| Monoisotopic Mass | 169.930244 g/mol |
| Topological Polar Surface Area | 80.3 Ų |
| Heavy Atom Count | 9 |
| Formal Charge | 0 |
| Complexity | 108 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 1 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
| 1 of 2 | |
|---|---|
| Drug Name | Ferrous fumarate |
| Active Ingredient | Ferrous fumarate |
| Dosage Form | Tablet |
| Route | oral |
| Strength | 75mg |
| Market Status | Tentative Approval |
| Company | Barr Labs |
| 2 of 2 | |
|---|---|
| Drug Name | Ferrous fumarate |
| Active Ingredient | Ferrous fumarate |
| Dosage Form | Tablet |
| Route | oral |
| Strength | 75mg |
| Market Status | Tentative Approval |
| Company | Barr Labs |
Used in preventing and treating iron-deficiency anemia.
The major activity of supplemental iron is in the prevention and treatment of iron deficiency anemia. Iron has putative immune-enhancing, anticarcinogenic and cognition-enhancing activities.
Trace Elements
A group of chemical elements that are needed in minute quantities for the proper growth, development, and physiology of an organism. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) (See all compounds classified as Trace Elements.)
B - Blood and blood forming organs
B03 - Antianemic preparations
B03A - Iron preparations
B03AA - Iron bivalent, oral preparations
B03AA02 - Ferrous fumarate
B - Blood and blood forming organs
B03 - Antianemic preparations
B03A - Iron preparations
B03AD - Iron in combination with folic acid
B03AD02 - Ferrous fumarate
Absorption
The efficiency of absorption depends on the salt form, the amount administered, the dosing regimen and the size of iron stores. Subjects with normal iron stores absorb 10% to 35% of an iron dose. Those who are iron deficient may absorb up to 95% of an iron dose.
Iron is necessary for the production of hemoglobin. Iron-deficiency can lead to decreased production of hemoglobin and a microcytic, hypochromic anemia.
Tenatra connects Indian manufacturers with global buyers through active partners in Germany, Switzerland, Belgium, Spain & Turkey.
Macsen Labs, a leader in Chemistry since 1952, specializing in APIs, specialty and fine chemicals, and dyes.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 33135
Submission : 2018-11-23
Status : Active
Type : IV

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 29276
Submission : 2015-03-25
Status : Active
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 34498
Submission : 2021-02-12
Status : Active
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 17321
Submission : 2004-04-16
Status : Inactive
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 211
Submission : 1940-01-01
Status : Inactive
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 24184
Submission : 2010-09-13
Status : Inactive
Type : IV
Certificate Number : R0-CEP 2010-147 - Rev 00
Issue Date : 2012-02-22
Type : Chemical
Substance Number : 902
Status : Withdrawn by EDQM F...

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 17321
Submission : 2004-04-16
Status : Inactive
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 33135
Submission : 2018-11-23
Status : Active
Type : IV

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 211
Submission : 1940-01-01
Status : Inactive
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 24184
Submission : 2010-09-13
Status : Inactive
Type : IV

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 29276
Submission : 2015-03-25
Status : Active
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 34498
Submission : 2021-02-12
Status : Active
Type : II

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Certificate Number : CEP 2004-232 - Rev 04
Status : Valid
Issue Date : 2025-01-21
Type : Chemical
Substance Number : 902

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Certificate Number : R1-CEP 2012-400 - Rev 00
Status : Valid
Issue Date : 2020-02-19
Type : Chemical
Substance Number : 902

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Certificate Number : R0-CEP 2010-147 - Rev 00
Status : Withdrawn by EDQM Failure to CEP pro...
Issue Date : 2012-02-22
Type : Chemical
Substance Number : 902

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] Registration Number : 221MF10120
Registrant's Address : Hauptstrasse 2 D-31860 Emmerthal Germany
Initial Date of Registration : 2009-06-16
Latest Date of Registration : 2009-06-16

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC Package Code : 11737-400
Start Marketing Date : 2005-02-01
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (0.6kg/kg)
Marketing Category : DRUG FOR FURTHER PROCESSING

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]About the Company : Jai Radhe Sales was founded in 1999 as an out-of-the-box distribution firm specializing in the global supply of high-quality pharmaceutical ingredients. The firm provides complete ...
About the Company : Pharm-Rx has earned an outstanding reputation since its establishment in 1991, serving as a reputable importer and distributor of active ingredients to the pharmaceutical, nutritio...
Tenatra connects Indian manufacturers with global buyers through active partners in Germany, Switzerland, Belgium, Spain & Turkey.
About the Company : Tenatra International was established as a proprietorship firm in 1999. It got off to a very good start, supporting clients in the United States, Mexico and Europe. As business opp...
Macsen Labs, a leader in Chemistry since 1952, specializing in APIs, specialty and fine chemicals, and dyes.
About the Company : Macsen is a USFDA registered, TGA GMP & WHO-GMP certified manufacturer and supplier of Active Pharmaceutical Ingredients (APIs), Biological Stains & Specialty Fine Chemicals. Our c...
About the Company : Atomgrid is a global company that specializes in the manufacturing and sourcing of specialty chemicals. The company manages end-to-end manufacturing and sourcing needs, covering R&...

About the Company : Dr. Paul Lohmann GmbH KG provides high-purity Calcium-, Iron-, Magnesium-, Zinc- and other mineral salts for the pharmaceutical and nutraceutical industries. In our GMP and DIN EN ...

About the Company : We take pride and pleasure to introduce “Envee Drugs Pvt. Ltd.” a leading manufacturer of Active Pharmaceutical Ingredients (APIs). Envee Drugs is a API manufacturer since 1998...

About the Company : India Phosphate, established in 2007, is a leading processor, exporter, and supplier of high-quality Calcium Phosphate. Known for its purity, accuracy, and cost-effectiveness, our ...

About the Company : Qualite Pharma is a global consultancy specializing in end-to-end solutions for pharmaceuticals, nutraceuticals, and cosmetics. With a strong presence in emerging markets (Myanmar,...

About the Company : Valaji PharmaChem is an ISO certified and a leading name in the field of Fine/ Specialty high purity chemicals with large manufacturing facilities located at Padra, Baroda, Gujarat...

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us
Details:
Ferrous Fumarate is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in clinical studies for the treatment of Anemia, Iron-Deficiency.
Lead Product(s): Ferrous Fumarate,Iron,Ascorbic Acid
Therapeutic Area: Hematology Brand Name: Undisclosed
Study Phase: UndisclosedProduct Type: Vitamins/Minerals/Inorganic Salts
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable March 12, 2024

Lead Product(s) : Ferrous Fumarate,Iron,Ascorbic Acid
Therapeutic Area : Hematology
Highest Development Status : Undisclosed
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Efficacious Iron for Iron Deficiency Anemia in Adults Aged ≥18 Years
Details : Ferrous Fumarate is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in clinical studies for the treatment of Anemia, Iron-Deficiency.
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
March 12, 2024

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
The generic version of Taytulla®1 Capsules, Norethindrone Acetate and Ethinyl Estradiol Capsules and Ferrous Fumarate Capsules, 1 mg/20 mcg, has received approval by the United States Food & Drug Administration.
Lead Product(s): Norethisterone Acetate,Ethinyl Estradiol,Ferrous Fumarate
Therapeutic Area: Obstetrics/Gynecology (Women’s Health) Brand Name: Norethindrone Acetate/Ethinyl Estradiol/Ferrous Fumarate-Generic
Study Phase: Approved FDFProduct Type: Miscellaneous
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable July 29, 2022

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Norethisterone Acetate,Ethinyl Estradiol,Ferrous Fumarate
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : The generic version of Taytulla®1 Capsules, Norethindrone Acetate and Ethinyl Estradiol Capsules and Ferrous Fumarate Capsules, 1 mg/20 mcg, has received approval by the United States Food & Drug Administration.
Product Name : Norethindrone Acetate/Ethinyl Estradiol/Ferrous Fumarate-Generic
Product Type : Miscellaneous
Upfront Cash : Inapplicable
July 29, 2022

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
U.S.FDA has approved Abbreviated New Drug Application for Merzee (Slayback Pharma), an AB-rated generic equivalent of Taytulla® (Allergan), an estrogen/progestin combination oral contraceptive indicated for use by women to prevent pregnancy.
Lead Product(s): Norethisterone Acetate,Ethinyl Estradiol,Ferrous Fumarate
Therapeutic Area: Obstetrics/Gynecology (Women’s Health) Brand Name: Merzee
Study Phase: Approved FDFProduct Type: Miscellaneous
Sponsor: Lupin Ltd
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable April 07, 2022

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Norethisterone Acetate,Ethinyl Estradiol,Ferrous Fumarate
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Lupin Ltd
Deal Size : Inapplicable
Deal Type : Inapplicable
Lupin Launches Merzee® Capsules in the United States
Details : U.S.FDA has approved Abbreviated New Drug Application for Merzee (Slayback Pharma), an AB-rated generic equivalent of Taytulla® (Allergan), an estrogen/progestin combination oral contraceptive indicated for use by women to prevent pregnancy.
Product Name : Merzee
Product Type : Miscellaneous
Upfront Cash : Inapplicable
April 07, 2022

Details:
Ferrous Fumarate is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Anemia, Iron-Deficiency.
Lead Product(s): Ferrous Fumarate,Inapplicable
Therapeutic Area: Hematology Brand Name: Undisclosed
Study Phase: Phase IVProduct Type: Vitamins/Minerals/Inorganic Salts
Sponsor: dr. J.M. Munster, gynaecologist, principal investigator
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable March 14, 2022

Lead Product(s) : Ferrous Fumarate,Inapplicable
Therapeutic Area : Hematology
Highest Development Status : Phase IV
Partner/Sponsor/Collaborator : dr. J.M. Munster, gynaecologist, principal investigator
Deal Size : Inapplicable
Deal Type : Inapplicable
The Efficacy of Intermittent Versus Daily Oral Iron Supplementation in Anaemic Pregnant Women.
Details : Ferrous Fumarate is a Vitamins/Minerals/Inorganic Salts drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Anemia, Iron-Deficiency.
Product Name : Undisclosed
Product Type : Vitamins/Minerals/Inorganic Salts
Upfront Cash : Inapplicable
March 14, 2022

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Details:
Taytulla® is an estrogen/progestin combination oral contraceptive indicated for use by women to prevent pregnancy. Annual market sales for Taytulla® for the twelve month period ending August, 2020 were $157 million, according to IQVIA™.
Lead Product(s): Norethisterone Acetate,Ethinyl Estradiol,Ferrous Fumarate
Therapeutic Area: Obstetrics/Gynecology (Women’s Health) Brand Name: Gemmily
Study Phase: Approved FDFProduct Type: Miscellaneous
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable November 09, 2020

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Norethisterone Acetate,Ethinyl Estradiol,Ferrous Fumarate
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Approved FDF
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Xiromed LLC Launches Gemmily™, First-to-Market Generic to Taytulla®
Details : Taytulla® is an estrogen/progestin combination oral contraceptive indicated for use by women to prevent pregnancy. Annual market sales for Taytulla® for the twelve month period ending August, 2020 were $157 million, according to IQVIA™.
Product Name : Gemmily
Product Type : Miscellaneous
Upfront Cash : Inapplicable
November 09, 2020

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
22
PharmaCompass offers a list of Ferrous Fumarate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ferrous Fumarate manufacturer or Ferrous Fumarate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ferrous Fumarate manufacturer or Ferrous Fumarate supplier.
PharmaCompass also assists you with knowing the Ferrous Fumarate API Price utilized in the formulation of products. Ferrous Fumarate API Price is not always fixed or binding as the Ferrous Fumarate Price is obtained through a variety of data sources. The Ferrous Fumarate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Ferrous Fumarate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ferrous Fumarate, including repackagers and relabelers. The FDA regulates Ferrous Fumarate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ferrous Fumarate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ferrous Fumarate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ferrous Fumarate supplier is an individual or a company that provides Ferrous Fumarate active pharmaceutical ingredient (API) or Ferrous Fumarate finished formulations upon request. The Ferrous Fumarate suppliers may include Ferrous Fumarate API manufacturers, exporters, distributors and traders.
click here to find a list of Ferrous Fumarate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Ferrous Fumarate DMF (Drug Master File) is a document detailing the whole manufacturing process of Ferrous Fumarate active pharmaceutical ingredient (API) in detail. Different forms of Ferrous Fumarate DMFs exist exist since differing nations have different regulations, such as Ferrous Fumarate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Ferrous Fumarate DMF submitted to regulatory agencies in the US is known as a USDMF. Ferrous Fumarate USDMF includes data on Ferrous Fumarate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Ferrous Fumarate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Ferrous Fumarate suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Ferrous Fumarate Drug Master File in Japan (Ferrous Fumarate JDMF) empowers Ferrous Fumarate API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Ferrous Fumarate JDMF during the approval evaluation for pharmaceutical products. At the time of Ferrous Fumarate JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Ferrous Fumarate suppliers with JDMF on PharmaCompass.
A Ferrous Fumarate CEP of the European Pharmacopoeia monograph is often referred to as a Ferrous Fumarate Certificate of Suitability (COS). The purpose of a Ferrous Fumarate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Ferrous Fumarate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Ferrous Fumarate to their clients by showing that a Ferrous Fumarate CEP has been issued for it. The manufacturer submits a Ferrous Fumarate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Ferrous Fumarate CEP holder for the record. Additionally, the data presented in the Ferrous Fumarate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Ferrous Fumarate DMF.
A Ferrous Fumarate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Ferrous Fumarate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Ferrous Fumarate suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Ferrous Fumarate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Ferrous Fumarate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Ferrous Fumarate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Ferrous Fumarate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Ferrous Fumarate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Ferrous Fumarate suppliers with NDC on PharmaCompass.
Ferrous Fumarate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ferrous Fumarate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ferrous Fumarate GMP manufacturer or Ferrous Fumarate GMP API supplier for your needs.
A Ferrous Fumarate CoA (Certificate of Analysis) is a formal document that attests to Ferrous Fumarate's compliance with Ferrous Fumarate specifications and serves as a tool for batch-level quality control.
Ferrous Fumarate CoA mostly includes findings from lab analyses of a specific batch. For each Ferrous Fumarate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ferrous Fumarate may be tested according to a variety of international standards, such as European Pharmacopoeia (Ferrous Fumarate EP), Ferrous Fumarate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ferrous Fumarate USP).